175 related articles for article (PubMed ID: 1310646)
1. Recurrence after breast ablation for ductal carcinoma in situ.
de Jong E; Peterse JL; van Dongen JA
Eur J Surg Oncol; 1992 Feb; 18(1):64-6. PubMed ID: 1310646
[TBL] [Abstract][Full Text] [Related]
2. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast.
Solin LJ; Fourquet A; Vicini FA; Haffty B; Taylor M; McCormick B; McNeese M; Pierce LJ; Landmann C; Olivotto IA; Borger J; de La Rochefordiere A; Schultz DJ
Cancer; 2001 Mar; 91(6):1090-7. PubMed ID: 11267953
[TBL] [Abstract][Full Text] [Related]
3. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
[TBL] [Abstract][Full Text] [Related]
4. Breast conserving surgery in the management of in situ breast carcinoma.
Graham MD; Lakhani S; Gazet JC
Eur J Surg Oncol; 1991 Jun; 17(3):258-64. PubMed ID: 1646128
[TBL] [Abstract][Full Text] [Related]
5. Breast-conserving therapy of ductal carcinoma in situ: frequency of local recurrence after wide excision with and without additional radiotherapy, a retrospective study of 42 cases.
Vrouenraets BC; Peterse JL; van Dongen JA
Neth J Surg; 1991 Jun; 43(3):51-5. PubMed ID: 1656327
[TBL] [Abstract][Full Text] [Related]
6. Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery.
Boland GP; Chan KC; Knox WF; Roberts SA; Bundred NJ
Br J Surg; 2003 Apr; 90(4):426-32. PubMed ID: 12673743
[TBL] [Abstract][Full Text] [Related]
7. Late recurrence of ductal carcinoma in situ at the cutaneous end of surgical drainage following total mastectomy.
Finkelstein SD; Sayegh R; Thompson WR
Am Surg; 1993 Jul; 59(7):410-4. PubMed ID: 8391769
[TBL] [Abstract][Full Text] [Related]
8. Therapy of in situ cancer.
Recht A; Connolly JL; Schnitt SJ; Harris JR
Hematol Oncol Clin North Am; 1989 Dec; 3(4):691-708. PubMed ID: 2558105
[TBL] [Abstract][Full Text] [Related]
9. Recurrence of breast carcinoma after breast conserving treatment.
Peterse JL; van Dongen JA; Bartelink H
Eur J Surg Oncol; 1988 Apr; 14(2):123-6. PubMed ID: 2834239
[TBL] [Abstract][Full Text] [Related]
10. The problem of ductal carcinoma in situ of the breast.
Fentiman IS
Ann Chir Gynaecol; 1992; 81(4):334-6. PubMed ID: 1336650
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
[TBL] [Abstract][Full Text] [Related]
12. Bilateral and multifocal breast carcinoma. A clinical and autopsy study with special emphasis on carcinoma in situ.
Ringberg A; Palmer B; Linell F; Rychterova V; Ljungberg O
Eur J Surg Oncol; 1991 Feb; 17(1):20-9. PubMed ID: 1847343
[TBL] [Abstract][Full Text] [Related]
13. Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history.
Hiramatsu H; Bornstein BA; Recht A; Schnitt SJ; Baum JK; Connolly JL; Duda RB; Guidi AJ; Kaelin CM; Silver EB; Harris JR
Cancer J Sci Am; 1995; 1(1):55-61. PubMed ID: 9166455
[TBL] [Abstract][Full Text] [Related]
14. Alternatives in the surgical management of in situ breast cancer. A meta-analysis of outcome.
Bradley SJ; Weaver DW; Bouwman DL
Am Surg; 1990 Jul; 56(7):428-32. PubMed ID: 2164336
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer-specific mortality after invasive local recurrence in patients with ductal carcinoma-in-situ of the breast.
Lee LA; Silverstein MJ; Chung CT; Macdonald H; Sanghavi P; Epstein M; Holmes DR; Silberman H; Ye W; Lagios MD
Am J Surg; 2006 Oct; 192(4):416-9. PubMed ID: 16978940
[TBL] [Abstract][Full Text] [Related]
16. Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up.
Ringberg A; Andersson I; Aspegren K; Linell F
Eur J Surg Oncol; 1991 Oct; 17(5):466-76. PubMed ID: 1657650
[TBL] [Abstract][Full Text] [Related]
17. Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma.
Pawlik TM; Perry A; Strom EA; Babiera GV; Buchholz TA; Singletary E; Perkins GH; Ross MI; Schecter NR; Meric-Bernstam F; Ames FC; Hunt KK; Kuerer HM
Cancer; 2004 Feb; 100(3):490-8. PubMed ID: 14745864
[TBL] [Abstract][Full Text] [Related]
18. [The treatment of carcinoma in situ of the breast].
Raudrant D; Golfier F; Unger P
Rev Fr Gynecol Obstet; 1990 Feb; 85(2):91-6. PubMed ID: 2157271
[TBL] [Abstract][Full Text] [Related]
19. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
[TBL] [Abstract][Full Text] [Related]
20. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
